期刊文献+

酶联免疫斑点试验检测技术(Elispot)在诊断结核性脑膜炎及Ⅲ型肺结核中的应用价值 被引量:9

Implication of Elispot assay for diagnosis of tuberculous meningoencephalitis and Ⅲ type pulmonary turberculosis
下载PDF
导出
摘要 目的评价酶联免疫斑点技术(Elispot)检测外周血结核杆菌抗原特异性r干扰素(IFN-r)水平在结核脑膜脑炎及Ⅲ型肺结核患者诊断中的应用价值。方法利用Elispot技术分别对383例结核病人(包括73例结核性脑膜炎患者、310例Ⅲ型肺结核患者)、97例健康人外周血结核杆菌抗原特异性r干扰素(IFN-r)水平进行定量检测。结果 Elispot技术在结核病中诊断敏感性为81.46%,特异性为85.57%;结核脑膜脑炎组Elispot阳性率为61.64%;Ⅲ型肺结核患者组Elispot阳性率为86.13%;健康对照组Elispot阳性率为10.31%;各组间比较差异具有统计学意义(P<0.05)。结论 Elispot技术在结核病诊断中具有良好的辅助诊断价值,在Ⅲ型肺结核中的诊断价值优于结核性脑膜脑炎。 Objective To investigate mycobactefium tuberculosis antigen specific IFN-r response(Elispot) in patients with tuberculous meningoencephafitis or Ⅲ type pulmonary turberculosis. Methods 383 cases of tuberculosis patients ( including 73 cases of tuber- culous meningoencephalitis and 310 cases of Ⅲ type pulmonary turberculosis ) and 97 healthy volunteers were enrolled in our study. The antigen specific IFN-r responses were evaluated by Elispot assay. Results The sensibility of Elispot in tuberculosis patients is 81.64% , and the specificity is 85.57%. Positive IFN-r response were detected in 61.64% tuberculous meningoencephalitis group, 86.13% in Ⅲ type pulmonary turberculosis group and 10.31% in healthy vvolunteers. There were statistical differences between groups (P 〈 0. 05 ). Conclusion Antigen-specific IFN-r Elispot assay could be a favourable assistant method in the diagnosis of Tuberculosis. It has better value in Ⅲ type pulmonary tuberculosis than in tuberculous meningoencephalitis.
出处 《临床肺科杂志》 2011年第5期721-722,共2页 Journal of Clinical Pulmonary Medicine
关键词 酶联免疫斑点技术(Elispot) 结核性脑膜脑炎 Ⅲ型肺结核 Elispot Tuberculous meningoencephalitis Ⅲ type pulmonary turberculosis
  • 相关文献

参考文献7

二级参考文献35

  • 1Madhukar Pai, Lee W Riley, and John M Colford Jr. Interferon- γassays in the immunodiagnosis of tuberculosis: a systematic review. Infectious Diseases Vol 4 December,2004,761 - 773.
  • 2Alton B,Farris, M D,John A. Branda, M.D. QuantiFERON- TB Gold Assay for Tuberculosis Infection. Clinical Microbiology Newsletter,2007,29 : 17129 - 135.
  • 3Mazurek G H. Guidelines for using the QuantiFERON-TB gold test for detecting Mycobacterium tuberculosis infection. United States MMWR Recomm,2005 Rep,54:49 -55.
  • 4Ajit Lalvani Diagnosing Tuberculosis Infection in the 21 st Century. CHEST, 2007,131: 1898 - 1906.
  • 5Mazurek G H. Guidelines for Using the QuantiFERON (R)-TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection. MMWR January,31,2003,15 - 19.
  • 6Morten Ruhwald, Morten Bjerregaard-Andersen, Paulo Rabna. et. al CXCL10/IP-IO release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes and Infection 9 (2007) 806- 812.
  • 7Locht C. Heparin-binding hemaggiutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberculosis ( Edinburgh, scotland ), 2006 May-Jul,86 ( 3 - 4 ) :303 - 309.
  • 8Hougardy J M. Heparin-Binding-Hemagglutinin-lnduced IFN-gamma Release as a Diagnostic Tool for Latent Tuberculosis. PLoS ONE ,2007 Oct 3,2(10) :e926.
  • 9Baba K. Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferongamma assay. BMC Infect Dis,2008 Mar, 14 : 8 - 35.
  • 10Kang Y A. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis burden country. JAMA ,2005,293:2756 - 2761.

共引文献124

同被引文献54

  • 1Ravn P, Munk ME, Andersen AB, et al. Prospective evaluation of a whole - blood test using Mycobacterium tuberculosis - specific antigens ESAT - 6 and CFP - 10 for diagnosis of active tuberculosis [ J ]. Clin Diagn Lab Immunol, 2005,12(4) :491 -496.
  • 2Madariaga MG, Jalali Z, Swindells S. Clinical utility of interferon gamma assay in the diagnosis of tuberculosis [ J ]. J Am Board Fam Med, 2007,20(6) :540 -547.
  • 3Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy [ J ]. Chest, 2007 , 131 (6) : 1898 - 1906.
  • 4Ahuja GK, Mohan K. K, Prasad k, et al. Diagnostic criteria for tuberculous meningitis and their validation [ J ]. Tuber Lung Dis, 1994,75 (2) :49 -52.
  • 5Die1 R, Loddenkemper R, Nienhaus A. Evidence- based comparison of commercial interferon - gamma release assays for detecting active TB: a meta- analysis[J]. Chest, 2010 ,137(4):952-968.
  • 6Mazurek G H, Jereh J, Lobue P, et aI. Guidelines for Using the Quanti FERON-TB Gold Test for Detecting Mycobacterium Tubercu- losis Infection [ J ]. United States. MMWR Recomm Rep,2005,54 (RR-15) :49 -55.
  • 7Richeldi L. An Update on the Diagnosis of Tuberculosis Infection [J]. Am J Respir Crit Care Med,2006,174(7) :736 -742.
  • 8中华医学会结核病学分会.肺结核诊断和治疗指南[J].中华结核病和呼吸杂志,2001,24:70-74.
  • 9Gordon SV, Brosch R, Billault A, et al. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays[J]. Mol Microbiol, 1999,32(3) :643-655.
  • 10Lewis KN, Liao R, Guinn KM, et al. Deletion of RDI from Mycobacterium tuberculosis mimics bacille Calmette Guerin attenuation[J]. J Infect Dis, 2003, 187 (1) : 117- 123.

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部